UniProt:P16410 CTLA4

chain
  • signal peptide:1-35
  • chain:36-223
checksum 6F9466FB2E139A5A
comment
  • FUNCTION Inhibitory receptor acting as a major negative regulator of T-cell responses (PubMed:11279501, PubMed:11279502, PubMed:16551244, PubMed:1714933, PubMed:18641304, PubMed:28484017). Acts as a decoy receptor: the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28 (PubMed:11279501, PubMed:11279502, PubMed:16551244, PubMed:1714933, PubMed:28484017).SUBUNIT Homodimer; disulfide-linked (PubMed:11279501, PubMed:11279502, PubMed:21156796, PubMed:28484017, Ref.24). Interacts with ICOSLG (PubMed:28484017).INTERACTION Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalization.ALTERNATIVE PRODUCTS Widely expressed with highest levels in lymphoid tissues. Detected in activated T-cells where expression levels are 30- to 50-fold less than CD28, the stimulatory coreceptor, on the cell surface following activation.PTM N-glycosylation is important for dimerization.PTM Phosphorylation at Tyr-201 prevents binding to the AP-2 adapter complex, blocks endocytosis, and leads to retention of CTLA4 on the cell surface.POLYMORPHISM Genetic variations in CTLA4 are associated with susceptibility to several autoimmune disorders (PubMed:10189842, PubMed:10924276, PubMed:12724780, PubMed:15138458, PubMed:15657618, PubMed:15688186, PubMed:18595775, PubMed:25213377, PubMed:25329329). They influence responsiveness to hepatitis B virus (HBV) infection [MIM:610424] (PubMed:15452244).DISEASE Disease susceptibility is associated with variants affecting the gene represented in this entry.DISEASE Genetic variations in CTLA4 may influence susceptibility to Graves disease, an autoimmune disorder associated with overactivity of the thyroid gland and hyperthyroidism.DISEASE Disease susceptibility is associated with variants affecting the gene represented in this entry.DISEASE Disease susceptibility is associated with variants affecting the gene represented in this entry.DISEASE The disease is caused by variants affecting the gene represented in this entry.PHARMACEUTICAL Engineered fusion proteins consisting of the extracellular domain of CTLA4 and the IgG Fc region (Ctla4-Ig), inhibit T-cell-dependent antibody responses, and are used as immunosuppressive agents. They are soluble, have an enhanced affinity for B7 ligands and act as a competitive inhibitor of CD28.MISCELLANEOUS The therapeutic antibody Ipilimumab competes for the binding site of the endogenous ligands CD80/B7-1, CD86/B7-2 and ICOSLG.ONLINE INFORMATION CLTA-4 entry
crossReference
databaseName UniProt
dbId 53042
description
  • recommendedName: Cytotoxic T-lymphocyte protein 4 alternativeName: Cytotoxic T-lymphocyte-associated antigen 4 shortName: CTLA-4 cdAntigenNameCD152/cdAntigenName
displayName UniProt:P16410 CTLA4
geneName
  • CTLA4
  • CD152
identifier P16410
isSequenceChanged false
keyword
  • 3D-structure
  • Adaptive immunity
  • Alternative splicing
  • Cell membrane
  • Diabetes mellitus
  • Disease variant
  • Disulfide bond
  • Glycoprotein
  • Immunity
  • Immunoglobulin domain
  • Membrane
  • Pharmaceutical
  • Phosphoprotein
  • Proteomics identification
  • Reference proteome
  • Signal
  • Systemic lupus erythematosus
  • Transmembrane
  • Transmembrane helix
modified [InstanceEdit:9983091] Weiser, Joel, 2026-02-20
moleculeType Protein
name
  • CTLA4
otherIdentifier
  • 11730636_a_at
  • 11730637_a_at
  • 11753826_x_at
  • 11753866_x_at
  • 1493
  • 16889819
  • 221331_PM_x_at
  • 221331_x_at
  • 231794_PM_at
  • 231794_at
  • 234362_PM_s_at
  • 234362_s_at
  • 236341_PM_at
  • 236341_at
  • 2523856
  • 2523857
  • 2523858
  • 2523859
  • 2523860
  • 2523861
  • 2523862
  • 8047692
  • 81915_at
  • A_14_P101727
  • A_23_P102481
  • A_33_P3396139
  • A_33_P3401556
  • GE62661
  • GO:0002250
  • GO:0002376
  • GO:0005515
  • GO:0005794
  • GO:0005886
  • GO:0006955
  • GO:0006974
  • GO:0009897
  • GO:0016020
  • GO:0030889
  • GO:0031410
  • GO:0042129
  • GO:0042130
  • GO:0043065
  • GO:0045334
  • GO:0045590
  • GO:0048471
  • GO:0050852
  • GO:0050853
  • GO:0098636
  • HMNXSV003041410
  • Hs.247824.2.S1_3p_a_at
  • Hs.313929.0.A1_3p_at
  • ILMN_1763487
  • ILMN_2261627
  • ILMN_2348905
  • M37245_at
  • PH_hs_0013114
  • TC02001201.hg
  • TC02003774.hg
physicalEntity
referenceDatabase [ReferenceDatabase:2] UniProt
referenceGene
referenceTranscript
schemaClass ReferenceGeneProduct
secondaryIdentifier
  • CTLA4_HUMAN
  • A0N1S0
  • E9PDH0
  • O95653
  • Q0PP65
  • Q52MC1
  • Q53TD5
  • Q5S005
  • Q8WXJ1
  • Q96P43
  • Q9UKN9
sequenceLength 223
species [Species:48887] Homo sapiens
stId uniprot:P16410
url http://purl.uniprot.org/uniprot/P16410
Cite Us!